by David Wright

A 2026 systematic review found that semaglutide 2.4 mg improved patient-reported physical functioning compared with placebo, but the average improvement fell below a published threshold for a noticeable within-person change. The result is a useful reminder to track how life is changing—not only the number on the scale.

Key takeaways

• Four STEP trials with 4,182 participants contributed physical-function data.
• Semaglutide improved physical-function scores versus placebo, but the average difference was below a published meaningful-change threshold.
• Weight-related quality-of-life improvements were also modest on average in the trials reviewed.
• Track function, energy, mobility, health markers, and sustainable routines—not weight alone.

The review asked a patient-centered question

Semaglutide 2.4 mg has produced substantial weight loss in randomized trials, but this review focused on a different outcome: whether people reported meaningful improvements in physical functioning and weight-related quality of life. Four placebo-controlled STEP trials with 4,182 participants contributed data for the SF-36v2 Physical Functioning measure.

The average physical-function difference was statistically significant but modest

Compared with placebo, semaglutide improved SF-36v2 Physical Functioning by an average of 1.71 points. The confidence interval ranged from 1.07 to 2.35 points. The authors noted that this pooled difference was below a 3.7-point published threshold for meaningful within-patient change. That distinction matters: a result can be statistically reliable without being large enough for the average person to experience as a major functional change.

Quality-of-life measures told a similar story

Two trials with 2,768 participants reported weight-related quality-of-life measures. Effects were larger in participants without type 2 diabetes and smaller in those with type 2 diabetes, but the average effects in both groups remained below published meaningful-change thresholds. The authors concluded that patient-reported outcomes improved statistically, while average functional gains were modest and should be communicated cautiously.

This does not mean weight treatment has no value

The analysis was not designed to re-litigate semaglutide’s effect on body weight. Instead, it highlights that weight, physical function, energy, mobility, sleep, pain, confidence, metabolic markers, and quality of life are related but not interchangeable outcomes. A person may experience meaningful benefits in some domains and less change in others.

Build a dashboard that reflects the life you want

When working on weight or metabolic health, consider tracking a small set of functional outcomes alongside weight: walking tolerance, strength, sleep quality, energy, ability to perform daily tasks, blood pressure or glucose when relevant, medication tolerance, and how consistently healthy routines fit real life. Medication decisions belong with a qualified prescriber; coaching can help translate medical goals into sustainable daily behaviors.

Questions people may ask

Does this mean semaglutide does not work?
No. This review focused on patient-reported physical function and quality of life, not whether semaglutide produces weight loss. It found statistically better patient-reported outcomes, but average functional gains were modest.

What should I track besides weight?
Depending on your goals and medical context: mobility, strength, sleep, energy, blood pressure or glucose, daily functioning, medication effects, nutrition quality, and consistency of activity can provide a broader picture.

Sources and related reading

Primary source: The Effect of Semaglutide on Quality of Life in Adults With Overweight or Obesity: A Brief Systematic Review and Meta-Analysis

Related practice article: Weight-loss maintenance and behavior change

Next step: Schedule an appointment

Stay connected: use this practice website’s existing subscription option for future educational articles.

Educational information only; not a substitute for individualized medical or nutrition advice, diagnosis, treatment, or prescribing guidance.